Technologies
Keros Therapeutics Inc (NASDAQ:KROS) 39.36% Above Its 52-Week Low, But Can It Keep Rising?
In last trading session, Keros Therapeutics Inc (NASDAQ:KROS) saw 0.74 million shares changing hands with its beta currently measuring 1.29. Company’s recent per share price